RazorMetrics Experiences Exponential Growth

RazorMetrics
RazorMetrics, a healthcare technology company focused on lowering drug costs that started a short 5 years ago, has shown exponential growth. From 2021 to 2022, the company grew 2x; from 2022 to 2023, RazorMetrics grew 11x. The rapid growth is a reflection of how important saving money on drug costs is around the country for employers, employees, health plans, and their members.

Share This Post

Austin health-tech startup hits 11x growth in 2023

AUSTIN, Texas, Jan. 8, 2024 /PRNewswire/ — RazorMetrics, a healthcare technology company focused on lowering drug costs that started a short 5 years ago, has shown exponential growth. From 2021 to 2022, the company grew 2x; from 2022 to 2023, RazorMetrics grew 11x. The rapid growth is a reflection of how important saving money on drug costs is around the country for employers, employees, health plans, and their members.

“Scaling rapidly can be a major challenge for start-ups. I am proud to say that our team performed admirably,” said Tom Dorsett, CEO and Founder of RazorMetrics. “We added new support staff and found very talented individuals to join our executive team. We are set up for a significant year of continued growth in 2024.”

Coming aboard the executive team is Bryan Menell, the new Chief Product Officer. Bryan’s 25+ years of experience scaling up small and large companies is exactly what RazorMetrics needs at this time. “I love working with a company on the verge of explosive growth. RazorMetrics approach to lowering drug spend for self-insured employers and health plans is hitting the market at the perfect time and we are ready for it.”  

RazorMetrics’ platform helps companies cut drug spend instead of headcount as budgets continue to tighten. In 2024, RazorMetrics will have partnerships with some of the country’s largest PBMs, health technology vendors, health plans, and brokers around the U.S. and its territories.

About RazorMetrics
RazorMetrics is a healthcare technology company whose SaaS-based platform uses AI to lower drug spend for health plans, self-insured employers, and organizations. RazorMetrics’ unique, physician-driven approach process is simple and requires no extra clicks in the EHR and no external programs or apps to access. Switches are straightforward and easy to make, and the entire process stays within the normal clinical workflow. The platform is complementary to existing pharmacy initiatives and works with PBMs and other drug cost savings solutions to optimize results. RazorMetrics is fully scalable and customizable to each client’s unique variables and formularies.  For more information, visit www.razormetrics.com.

Media Contact:
Casey DeMoss, RazorMetrics
[email protected]

More To Explore

Article

Employer Benefit Costs Going Up in 2025

Analysts predict another difficult year for employers as health benefit costs are slated to rise by 5.8% Mercer’s recent “National Survey of Employer Sponsored Health Plans” predicts the surge in 2025 will mimic the increases seen in 2023 and 2024. The substantial annual increase is a shift from previous decades, where annual increases hovered around 3%. Without implementing cost-cutting measures, employees could see a jump in their premiums and copays.

Article

A New Way to Manage the GLP-1 Explosion

GLP-1 receptor agonists are all the rage these days for the promise of easy weight loss. GLP1s are FDA-approved for managing Type 2 diabetes but physicians are prescribing the medication for off-label use to help their patients lose weight. Between 2020 and 2023, the use of GLP-1 medications such as Ozempic and Wegovy, increased sharply due to off-label prescriptions. While these medications are very effective, they are also very expensive, which is challenging insurers, employers, and patients alike. As the demand for GLP-1 drugs continues to grow, particularly for weight loss, understanding the complexities of coverage and finding cost-saving strategies has become a top priority.

Ready to Get Started?

We're Here

To Help You Save

And, we are waiting…
Contact us, and we will be more than happy to answer all of your questions.